Accentia Biopharmaceuticals Reports Fiscal Third Quarter 2006 Financial Results; Accentia Biopharmaceuticals Reaches Significant Milestones, Including Commercial Launch Of MD Turbo In Late June

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) has released the financial results for its fiscal 2006 third quarter, ended June 30, 2006.

MORE ON THIS TOPIC